SOPHiA GENETICS partners with Nigeria's Syndicate Bio for liquid biopsy implementation, bringing genomic profiling to African patients.
SOPHiA GENETICS announces Nigeria's Syndicate Bio as its first liquid biopsy customer in Africa. The lab will implement MSK-ACCESS® powered by SOPHiA DDM™, making comprehensive genomic profiling and liquid biopsy available to patients across the continent. This collaboration with SOPHiA GENETICS, Memorial Sloan Kettering Cancer Center (MSK), and Syndicate Bio aims to advance health equity globally.
April 23, 2024
3 Articles